Your browser doesn't support javascript.
loading
New reference limits for cardiac troponin T and N-terminal b-type natriuretic propeptide in elders.
Heikkilä, Elisa; Katajamäki, Taina; Salminen, Marika; Irjala, Kerttu; Viljanen, Anna; Koivula, Marja-Kaisa; Pulkki, Kari; Isoaho, Raimo; Kivelä, Sirkka-Liisa; Viitanen, Matti; Löppönen, Minna; Vahlberg, Tero; Viikari, Laura.
Afiliación
  • Heikkilä E; Faculty of Medicine, Department of Clinical Chemistry, University of Turku, Turku, Finland; Southwest Finland Wellbeing Services County, Turku University Hospital, Laboratory Division, Turku, Finland. Electronic address: etmhei@utu.fi.
  • Katajamäki T; Faculty of Medicine, Department of Clinical Chemistry, University of Turku, Turku, Finland; Southwest Finland Wellbeing Services County, Turku University Hospital, Laboratory Division, Turku, Finland.
  • Salminen M; Faculty of Medicine, Department of General Practice, University of Turku and Turku University Hospital, Turku, Finland; Southwest Finland Wellbeing Services County, Turku University Hospital Services, Geriatric Medicine, 20521 Turku, Finland.
  • Irjala K; Faculty of Medicine, Department of Clinical Chemistry, University of Turku, Turku, Finland.
  • Viljanen A; Southwest Finland Wellbeing Services County, Turku University Hospital, Domain of General Practice and Rehabilitation, Turku, Finland; Faculty of Medicine, Department of Geriatrics, University of Turku and Turku University Hospital, Turku, Finland.
  • Koivula MK; HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland; Faculty of Medicine, Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.
  • Pulkki K; HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland; Faculty of Medicine, Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.
  • Isoaho R; Faculty of Medicine, Department of General Practice, University of Turku and Turku University Hospital, Turku, Finland.
  • Kivelä SL; Faculty of Medicine, Department of General Practice, University of Turku and Turku University Hospital, Turku, Finland; Faculty of Pharmacy, Division of Social Pharmacy, University of Helsinki, Helsinki, Finland.
  • Viitanen M; Faculty of Medicine, Department of Geriatrics, University of Turku and Turku University Hospital, Turku, Finland.
  • Löppönen M; Southwest Finland Wellbeing Services County, Turku University Hospital Services, General Medicine, Finland.
  • Vahlberg T; Faculty of Medicine, Department of Biostatistics, University of Turku and Turku University Hospital, Turku, Finland.
  • Viikari L; Southwest Finland Wellbeing Services County, Turku University Hospital Services, Geriatric Medicine, 20521 Turku, Finland; Southwest Finland Wellbeing Services County, Turku University Hospital, Domain of General Practice and Rehabilitation, Turku, Finland.
Clin Chim Acta ; 556: 117844, 2024 Mar 15.
Article en En | MEDLINE | ID: mdl-38403147
ABSTRACT
BACKGROUND AND

AIMS:

Our aim was to define reference limits for cardiac troponin T (cTnT) and N-terminal pro B-type natriuretic peptide (proBNP) that would better reflect their concentrations in older people. In addition, the incidence of acute myocardial infarctions (AMIs) was studied using these reference limits in an older population with and without previous heart diseases. MATERIALS AND

METHODS:

A population-based study with a ten-year follow-up. The reference population was formed by 763 individuals aged over 64 years, with no diagnoses of heart or kidney diseases.

RESULTS:

There was a significant increase in cTnT and proBNP concentrations with age. The 99 % reference limits for cTnT were 25 ng/L, 28 ng/l, 38 ng/l, and 71 ng/l for men in five-year-intervals starting from 64 to 69 years to 80 years and older, and 18 ng/L, 22 ng/l, 26 ng/l, and 52 ng/L for women, respectively. The 97.5 % reference limits for proBNP were 272 ng/L, 287 ng/l, 373 ng/l and 686 ng/L for men, and 341 ng/L, 377 ng/l, 471 ng/l, and 794 ng/L for women, respectively. Elevated proBNP was statistically significantly associated with future AMIs in subjects with and without a previous heart disease.

CONCLUSIONS:

Age-specific reference limits for cTnT and proBNP are needed to better evaluate cardiac symptoms.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Cardiopatías / Infarto del Miocardio Límite: Aged / Female / Humans / Male Idioma: En Revista: Clin Chim Acta / Clin. chim. acta / Clinica chimica acta Año: 2024 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Cardiopatías / Infarto del Miocardio Límite: Aged / Female / Humans / Male Idioma: En Revista: Clin Chim Acta / Clin. chim. acta / Clinica chimica acta Año: 2024 Tipo del documento: Article